The prevalence of the duodenal ulcer promoting gene (dupA) in Helicobacter pylori isolates varies by ethnic group and is not universally associated with disease development: a case-control study by Schmidt, Heather-Marie A et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
Gut Pathogens
Open Access Research
The prevalence of the duodenal ulcer promoting gene (dupA) in 
Helicobacter pylori isolates varies by ethnic group and is not 
universally associated with disease development: a case-control 
study
Heather-Marie A Schmidt1, Sönke Andres2,3, Nadeem O Kaakoush1, 
Lars Engstrand2,3, Lena Eriksson3, Khean-Lee Goh4, Kwong Ming Fock5, 
Ida Hilmi4, Subbiah Dhamodaran5, David Forman6 and Hazel Mitchell*1
Address: 1School of Biotechnology and Biomolecular Sciences, University of New South Wales, NSW, Sydney, Australia, 2Department of 
Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden, 3Department of Bacteriology, Swedish Institute for Infectious 
Disease Control, Solna, Sweden, 4Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia, 5Division of 
Gastroenterology, Department of Medicine, Changi General Hospital, Singapore and 6Centre for Epidemiology and Biostatistics, Faculty of 
Medicine and Health, Leeds University, Leeds, UK
Email: Heather-Marie A Schmidt - heather-marie.schmidt@student.unsw.edu.au; Sönke Andres - sonke.andres@smi.se; 
Nadeem O Kaakoush - nadok5@gmail.com; Lars Engstrand - lars.engstrand@smi.se; Lena Eriksson - lena.eriksson@smi.se; Khean-
Lee Goh - klgoh56@tm.net.my; Kwong Ming Fock - Kwong_Ming_Fock@cgh.com.sg; Ida Hilmi - Ihilmi@tm.net.my; 
Subbiah Dhamodaran - S_Dhamodaran@cgh.com.sq; David Forman - D.Forman@leeds.ac.uk; Hazel Mitchell* - h.mitchell@unsw.edu.au
* Corresponding author    
Abstract
Background: The putative H. pylori pathogenicity-associated factor dupA has been associated with
IL-8 induction in vitro, and duodenal ulcer (DU) and gastric cancer (GC) development in certain
populations, but this association is inconsistent between studies. We aimed to investigate dupA
prevalence in clinical isolates from Sweden, Australia and from ethnic Chinese, Indians and Malays
resident in Malaysia and Singapore and to examine the association with DU and GC. In addition we
investigated the sequence diversity between isolates from these diverse groups and compared the
level of IL-8 secretion in isolates possessing and lacking dupA.
Methods: PCR primers were designed to amplify over the C/T insertion denoting a continuous
dupA. PCR products from 29 clinical isolates were sequenced and compared with sequences from
three additional strains obtained from GenBank. Clinical isolates from 21 Malaysian patients (8
dupA-positive, 14 dupA-negative) were assessed for their ability to induce IL-8 in AGS cells in vitro.
Statistical analysis was performed using Fisher's exact test.
Results: The prevalence of dupA  in isolates from Swedish functional dyspepsia (FD) control
patients (65%, 13/20) was higher and in isolates from Indian FD patients (7.1%, 3/42) was lower as
compared with isolates from Chinese (28.9%, 13/49, P = 0.005, P = 0.025), Malay (35.7%, 5/14, P =
0.16, P = 0.018) and Australian (37.8%, 17/45, P = 0.060, P < 0.001) FD patients. dupA was
associated with DU and GC development in Chinese with 62.5% (10/16) and 54.6% (12/22) of
isolates possessing dupA respectively as compared with FD controls (28.9%) (P = 0.015, P = 0.032).
No significant difference in prevalence of dupA between FD controls, DU (63.6%, 7/11) and GC
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(61.9%, 13/21) cases (P = 1.000) was observed in the Swedish population. Sequence analysis
revealed a pairwise variation of 1.9% and all isolates possessed the C/T insertion. The average IL-
8 induction was 1330 pg/mL for dupA-positive isolates and 1378 pg/mL for dupA-negative isolates.
Conclusion:  Although  dupA  is highly conserved when present, we identified no consistent
association between dupA and DU or GC development across the ethnic groups investigated, with
the dupA prevalence in control groups varying significantly. Our results would suggest that in the
clinical isolates investigated dupA is not associated with IL-8 induction in vitro.
Introduction
Although Helicobacter pylori infection invariably results in
gastritis, a significant minority of those infected will
progress to more severe gastroduodenal pathologies,
including Duodenal Ulcer (DU) and Gastric Cancer (GC).
The factors resulting in progression to severe H. pylori-
related disease are poorly understood, however there is
compelling evidence to suggest a co-contribution of bac-
terial virulence factors, host genetics and environmental
stimuli [1].
To date a number of H. pylori pathogenicity-associated fac-
tors, including flagella, adhesins, urease, the vacuolating
cytotoxin and the cag pathogenicity island (cag PAI) have
been associated with the development of more serious H
pylori-related disease outcomes. The cag  PAI encodes a
type IV secretion system (TFSS), homologous to the well-
studied virB/D4 TFSS of the plant pathogen Agrobacterium
tumefaciens, as well as the effector protein CagA [2,3].
Translocation of CagA by the TFSS into gastric epithelial
cells has been shown to drive deregulation of intracellular
signaling pathways resulting in a myriad of cellular effects
such as increased motility and elongation [4]. In a process
independent of CagA, the TFSS also induces the produc-
tion of the chemo-attractant and pro-inflammatory
cytokine IL-8 by facilitating the entry of peptidoglycan
into the host epithelial cell [5]. In vitro studies have dem-
onstrated that the virB4  homologous ATPase, CagE
(HP0544, JHP0492), is essential for IL-8 induction [6-10].
In addition to cagE, multiple virB4  homologues exist
within the H. pylori genome, with both sequenced strains
J99 and 26695 possessing three additional virB4 homo-
logues [11,12]. Recently Lu et al. demonstrated that the
partial virB4 homologues JHP0917 and JHP0918, which
are present in the plasticity zone of J99 but not 26695,
form one continuous gene in clinical isolates the duode-
nal ulcer promoting gene (dupA). and that this gene was a
functional  virB4  homologous ATPase [13]. dupA, like
cagE, is associated with IL-8 induction [13] and thus it is
possible that this may be part of an as yet unidentified
TFSS. In the original study examining the role of dupA in
more severe H. pylori related disease, dupA possessing iso-
lates were found to be associated with the development of
DU in patients from Columbia, Japan and Korea [13]. In
contrast no association was found with gastric cancer sug-
gesting that dupA, and the TFSS it is associated with, may
be a major determinant in DU-development. In contrast,
two recent studies, one in Brazil [14] and a second in
which subjects from Belgium, China, South Africa and the
USA were examined [15] did not find an association
between dupA and DU development. Given that H. pylori
pathogenicity-associated factors in isolates from different
populations have been shown to possess distinct geno-
types [16-18], it is important that the association between
a newly identified putative pathogenicity-associated fac-
tor, such as dupA  and specific disease outcomes, be
assessed in clinical isolates from a range of different
regions and ethnic groups [19].
In the present study we determined the prevalence of dupA
across a range of countries and ethnic groups including
Australia, Sweden and the three primary ethnic groups res-
ident within Malaysia, namely Chinese, Indians and
Malays and examined the relationship between dupA and
DU and GC in the Swedish and ethnic Chinese popula-
tions. We also sequenced dupA PCR products from isolates
from each ethnic and disease group and determined that
they possessed the C/T insertion required for a continuous
dupA gene, and additionally that there was a only a small
degree of sequence diversity between isolates. Finally, we
determined that the induction of IL-8 secretion by AGS
cells was not associated with the presence of dupA in the
clinical isolates investigated in vitro.
Methods
Patients, H. pylori strains and extraction of genomic DNA
Malaysian & Singaporean
As part of a larger study examining the role of bacterial,
host and environmental factors in GC development, gas-
tric biopsies were obtained from consecutively enrolled
unrelated patients undergoing routine endoscopic exami-
nation of gastrointestinal symptoms at the University
Hospital, Kuala Lumpur, Malaysia and the Changi Hospi-
tal, Singapore (between mid-2004 and 2007). Based on
endoscopic and histological examination, patients were
diagnosed with either distal GC or functional dyspepsia
(FD). Gastric biopsies were stored at -70°C in brain heart
infusion (BHI) broth containing 20% glycerol and trans-
ported to Australia on dry ice. Gastric biopsies were
smeared onto campylobacter selective medium (CSA),Gut Pathogens 2009, 1:5 http://www.gutpathogens.com/content/1/1/5
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incubated and identified using morphology, microscopy
and biochemical tests as previously described [20,21].
Genomic DNA from one single colony isolate per patient
was extracted using the Gentra Puregene DNA extraction
kit (Gentra, Minneapolis, Minnesota, USA). In the present
study, 142 single colony isolates from 52 Chinese, 42
Indian and 14 Malay FD patients, 22 Chinese GC patients,
and 16 Chinese DU patients were included.
Swedish
In a previous case-control study which recruited patients
from eight hospitals in Sweden biopsies were collected,
cultured for H. pylori and bacterial DNA extracted as pre-
viously described [22]. In the present study 52 single col-
ony isolates from Swedish patients diagnosed with FD
(20), DU (11) and GC (21) were included.
Australian
In a previous study which recruited patients from Sydney,
Australia, biopsies were collected, cultured for H. pylori
and bacterial DNA extracted as previously described [23].
In the present study, 45 single colony isolates from Cau-
casian Australian patients with FD were included.
Primer design and detection of dupA in single colony 
isolates
Primer pair dupA1274F  and  dupA1674R  (table 1) were
designed to amplify a 399–400 bp fragment correspond-
ing to nucleotides 1016315–1016714 in J99 (accession
no. AE001439). The PCR primers amplified over the
region of dupA  containing the 1 bp insertion/deletion
detected by Lu et al. 2005 [13], that is the forward primer
bound to a sequence from JHP0917 and the reverse
primer bound to a sequence from JHP0918, suggesting
that PCR positive isolates have both JHP0917 and
JHP0918. PCR was performed in a 25 μL reaction contain-
ing 0.825 U Taq DNA polymerase (Fisher Biotech, Subi-
aco, Australia), 45 nmol magnesium-chloride, 10 pmol of
each primer and 10 ng of genomic DNA. All PCR runs
included a negative control (no DNA) and a positive con-
trol (J99). PCR was performed as follows: initial denatur-
ation for 5 minutes at 95°C, followed by 35 cycles of
95°C for 20 seconds, 55°C for 20 seconds and 72°C for
40 seconds, and a final at 72°C for 7 minutes. PCR prod-
ucts were visualized by agarose gel electrophoresis.
Validation of primers and investigation of dupA by DNA 
sequencing
29 single colony isolates (4 Chinese, 2 Indian, 4 Malay, 3
Australian and 3 Swedish FD isolates, 4 Chinese and 3
Swedish DU isolates, and 3 Chinese and 3 Swedish GC
isolates) were sequenced to validate the specificity of the
primers  dupA F and  dupA  R and to ascertain whether
JHP0917-0918 formed a single continuous gene in these
isolates. Sequencing was performed using the BigDye™
Terminator version 3.1 (Applied Biosystems, Foster City,
California, USA). Sequencing analysis was performed on
an ABI3730 Capillary DNA sequencer (GENterprise,
Mainz, Germany). Sequences were verified using Blast
[24] available from Biomanager by ANGIS http://
www.angis.org.au. Sequence alignments of the 29 strains,
with the original dupA gene sequence from Gene Bank
(accession no. AB196363) [13] and two additional dupA-
like sequences (accession no. EF076755 and EF076756)
available in the GenBank database http://
www.ncbi.nlm.nih.gov/Genbank/index.html were cre-
ated using ClustalW accurate [25] also available from
BioManager.
Development of a dupA multiplex PCR
To confirm that isolates negative for the dupA PCR truly
lacked the dupA  gene, rather than being the result of
sequence diversity over the primer annealing site, a multi-
plex PCR was designed involving the use of 2 forward
(dupA113F and dupA1274F) and 3 reverse (dupA1083R,
dupA1674R and dupA1830R) primers which produce 5
differently sized PCR products if all primers bind (Figure
1). Primer sequences are presented in table 1.
The PCR was performed in a 25 uL reaction as described
above, with an initial denaturation for 5 minutes at 95°C,
followed by 35 cycles of 95°C for 30 seconds, 50°C for 30
Table 1: PCR primers used in this study.
Primer name Nucleotide sequence (5'-3') Reference
dupA113F GAC GAT TGA GCG ATG GGA ATA T [15]
dupA1083R CTG AGA AGC CTT ATT ATC TTG TTG G [15]
dupA1274F GCG TGA TCA ATA TGG ATG CTT TTG C This study
dupA1674R TTG TCT GGC TCT CAT GTC CGT GTT G This study
dupA1830R CTT CCT TAT AAG TTT CTT GGT TTG C [15]Gut Pathogens 2009, 1:5 http://www.gutpathogens.com/content/1/1/5
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seconds and 65°C for 2 minutes, and a final at 65°C for 7
minutes.
Infection assay and IL-8 induction in vitro
AGS cells (ATCC CRL-1739) were routinely maintained in
RMPI1640 supplemented with 10% FCS and glutamine
(All from Gibco Invitrogen, Paisley, UK), and were cul-
tured at 37°C in 5%CO2/95% air. Cells were seeded in 24-
well tissue culture plates and infected with approximately
3 × 107 bacterial cells. 22 H. pylori isolates from Malaysian
patients (8 dupA-positive and 14 dupA-negative) were
available for in vitro analysis. Two H. pylori control strains
(67:20 (cag PAI negative) and 67:21 (cag PAI positive)
[26] were also available for in vitro analysis. H. pylori iso-
lates were cultured overnight in brucella broth (Sigma)
supplemented with 5% FCS (Gibco Invitrogen). Bacteria
were added to AGS cells in duplicate, and were co-incu-
bated for 6 hours before cell culture supernatant was col-
lected and stored at -20°C prior to use. At least three
independent experiments were performed; results repre-
sent the average for these experiments. The concentration
of IL-8 in the supernatant was analysed by ELISA, using
the BD OptEIA: Human IL-8 ELISA set (BD, San Diego,
CA, USA) according to the manufacturers instructions.
Statistical Analysis
Fisher's exact test was used to calculate statistical signifi-
cance; two-sided P values < 0.05 were considered signifi-
cant.
Sequences have been deposited in GenBank under the fol-
lowing accession numbers: EU253504–EU253532.
Results
Prevalence of dupA
Following PCR analysis, dupA  was identified in 15/52
(28.9%) Chinese, 5/14 (35.7%) Malay, 3/42 (7.1%)
Indian, 17/45 (37.8%) Australian and 13/20 (65.0%)
Swedish FD clinical isolates (table 2). The prevalence of
dupA in Swedish FD isolates was higher (P = 0.005, P =
PCR amplification using the dupA multiplex PCR Figure 1
PCR amplification using the dupA multiplex PCR. (A)Genomic DNA from H. pylori strains J99 (positive control), 26695 
(negative control) and FD527 (clinical isolate) were used to PCR amplify dupA using the forward primers dupA113F and 
dupA1274F, and the reverse primers dupA1083R, dupA1674R and dupA1830R. M, size markers (in base pairs). (B) Schematic 
representation of dupA showing the annealing positions of the forward primers dupA113F and dupA1274F, and the reverse 
primers dupA1083R, dupA1674R and dupA1830R, and the expected sizes of the amplified PCR products.
2686
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692
501/489
404
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0.162, P = 0.025) and the prevalence in Indian FD isolates
was lower (P = 0.025, P = 0.0517, P = 0.094) as compared
with the Chinese, Malay and Australian FD isolates inves-
tigated. There was no significant difference in the preva-
lence of dupA between isolates from Chinese, Malay and
Australian FD patients (P = 0.052 to P = 1.000). Among
isolates from Chinese or Swedish DU patients there was
no significant difference between the two ethnicities, with
10/16 (62.5%) and 7/11 (63.6%) of the isolates possess-
ing dupA respectively (P = 1.000). Similarly, there was no
significant difference between isolates from Chinese and
Swedish GC patients with 12/22 (54.6%) and 13/21
(61.9%) isolates possessing dupA respectively (P = 0.759).
Among isolates from Chinese patients, the prevalence of
isolates possessing dupA was significantly higher in iso-
lates from DU and GC patients than in isolates from FD
control patients (P = 0.015, P = 0.032), suggesting an asso-
ciation with the development of disease in this popula-
tion. There was no significant difference in dupA
prevalence between the isolates from Chinese DU and
Chinese GC patients (P = 0.744). Conversely, there was
no significant difference in the prevalence of dupA
between isolates from Swedish FD, DU and GC patients
(P = 1.000).
Sequence Analysis
Blast analysis of sequences from 29 clinical isolates
revealed significant sequence similarity to the dupA gene
sequence deposited in GenBank, accession no.
AB196363[13] and the sequence of a dupA-like protein
with GenBank accession no. EF076755. Of the 4 Chinese,
2 Indian, 4 Malay FD, 3 Swedish FD and 3 Australian FD
isolates, 4 Chinese and 3 Swedish DU isolates, and 3 Chi-
nese and 3 Swedish GC isolates, all isolates were observed
to possess a 1 bp C or T insertion after position 1385 rel-
ative to gene JHP0917 in J99 suggesting the presence of 1
continuous open-reading frame.
Sequence alignments from the 29 clinical isolates with 3
comparable sequences deposited in GenBank (AB196363,
EF076755, EF076756) revealed that dupA  possessed a
pair-wise sequence variation of only 1.90/100 bp (maxi-
mum variation: 14.71/100 bp, minimum variation 0.46/
100 bp, median variation 0.92/100 bp, standard devia-
tion 3.16/100 bp). Two isolates examined (the Chinese
FD isolate FD553 (GenBank sequence: EU253520) and
Iranian isolate EF076756), demonstrated a sequence vari-
ations of 14.71/100 bp and 12.64/100 bp respectively,
being more than 2 standard variations above the mean. In
the case of FD553 the high degree of sequence variation
was the direct result of a 60 bp insertion at base pair 1465
relative to AB196363. The remaining isolates were within
1 standard deviation of the mean.
Multiplex PCR
The use of the multiplex PCR revealed no additional iso-
lates positive for dupA, when compared to the use of
dupA1274F and dupA1674R alone, suggesting that the use
of the single primer pair is adequate to determine the
prevalence of dupA in both western and east Asian popu-
Table 2: Comparison of dupA prevalence between ethnic groups and countries.
Ethnicity/
Country
Australian Chinese Indian Malay Swedish
Diagnosis FD FD DU GC FD FD FD DU GC
Ethnicity Diagnosis Prevalence 
(%)
37.4 28.9 62.5 54.6 7.1 37.7 65.0 63.6 61.9
Australian FD (n = 45) 37.4 P = 1.000 P = 0.237 P < 0.001 P = 1.000 P = 0.060
Chinese FD (n = 52) 28.9 P = 0.237 P = 1.000 P = 0.015 P = 0.032 P = 0.025 P = 0.052 P = 0.005
DU (n = 16) 62.5 P = 0.015 P = 1.000 P = 0.744 P = 1.000
GC (n = 22) 54.6 P = 0.032 P = 0.744 P = 1.000 P = 0.760
Indian FD (n = 42) 7.1 P < 0.001 P = 0.025 P = 1.000 P = 0.018 P < 0.001
Malay FD (n = 14) 37.7 P = 1.000 P = 0.052 P = 0.018 P = 1.000 P = 0.163
Swedish FD (n = 20) 65.0 P = 0.060 P = 0.005 P < 0.001 P = 0.163 P = 1.000 P = 1.000 P = 1.000
DU (n = 11) 63.6 P = 1.000 P = 1.000 P = 1.000 P = 1.000
GC (n = 21) 61.9 P = 0.760 P = 1.000 P = 1.000 P = 1.000
Comparison of the prevalence of dupA-positive clinical isolates as determined by PCR between FD (functional dyspepsia), DU (duodenal ulcer) and 
GC (gastric cancer) patients from Australia, Sweden and the 3 primary ethnic groups of Malaysia and Singapore (Chinese, Indian and Malay). The 
statistical significance (P-values) of each valid comparison is displayed.Gut Pathogens 2009, 1:5 http://www.gutpathogens.com/content/1/1/5
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lations. An example of the multiplex PCR is presented in
figure 1; all five bands are clearly distinguishable in clini-
cal isolate FD527.
In vitro IL-8 production
The uninoculated control secreted 13 pg/ml, with the neg-
ative control strain (67:20) secreting 80 pg/ml and the
positive control strain (67:21) secreting 1368 pg/ml (fig-
ure 2A). Individual IL-8 secretion levels varied between
126 pg/ml and 1855 pg/ml for dupA-positive isolates, and
123 pg/ml and 1633 pg/ml for dupA-negative isolates.
However, no significant difference (p > 0.5) was observed
in the average level of IL-8 secreted by AGS cells between
clinical isolates possessing dupA (1330 pg/mL) and those
lacking dupA (1378 pg/mL) (figure 2B).
Discussion
The current investigation of the prevalence of dupA in clin-
ical isolates from Australia and Sweden as well as from the
three major ethnic groups (Chinese, Indians and Malays)
resident in Malaysia and Singapore clearly shows that
there is significant variability in the prevalence of dupA
between not only geographical locations, but also
between ethnic groups resident in the same country. In
the present study the prevalence of dupA in H. pylori iso-
lates collected from FD patients varied significantly
between nationalities/ethnicities, with isolates from
Swedish patients being significantly more likely to possess
dupA (65.0%) than isolates from Australia (26.3%) or eth-
nic Chinese (28.9%), Indians (7.1%) or Malays (35.7%)
resident in Malaysia or Singapore. Interestingly isolates
from ethnic Indian FD patients were significantly less
likely to possess dupA (7.1%) than isolates from any of the
other groups. This difference in dupA prevalence between
countries and ethnic groups is supported by several stud-
ies [15,27] including the initial Lu et al. 2005 [13] which
identified that dupA was more prevalent in isolates from
Columbian gastritis patients (39%) than in isolates from
Japanese (14%) and Koreans (7%) gastritis patients. Fur-
thermore, there is no significant difference in dupA preva-
lence reported previously for isolates from Chinese
patients (25% and 35.3% respectively) [15,28] and for
isolates from ethnic Chinese Malaysians and Singapore-
ans reported in the present study (28.9%), despite differ-
ent primer pairs being used, suggesting that the primer
pair designed in this study is appropriate. Conversely, the
prevalence reported in a north Indian population was
considerably higher than that found in the ethnic Indian
Malaysians in the present study (16/70 as compared with
3/42) [29]. One possible explanation is that the Indian
Malaysians are likely to be predominantly ethnic Tamil
[29], originating from Southern India, rather than the
north Indian Indeed, two studies in Brazil reported signif-
icantly different prevalences for dupA (92.3% vs. 62%)
[14,30].
IL-8 induction in AGS cells by clinical isolates in vitro Figure 2
IL-8 induction in AGS cells by clinical isolates in vitro. (A) Induction of IL-8 secretion in AGS cells incubated with indi-
cated strains for 6 hours. The error bars show the standard deviations of each independent experiment. (B) Average induction 
of IL-8 secretion in AGS cells incubated with dupA positive (blue) or negative (red) strains. The error bars show the standard 
deviations for each group of strains.
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We also demonstrated that the association between dupA
and severe gastroduodenal disease was inconsistent
between the Chinese and Swedish populations. In isolates
from ethnic Chinese patients the prevalence of dupA was
significantly higher in patients diagnosed with DU
(62.5%) or GC (54.6%) as compared with those diag-
nosed with FD. This is in contrast to the observations of
Lu  et al. 2005 [13] and Zhang et al. 2008 [28] who
reported a negative association with GC, but supports the
observations by Argent et al. [15]. In contrast, in the Swed-
ish population there was no significant difference in the
prevalence of dupA in isolates from patients diagnosed
with DU, GC or FD, similar to findings reported from Bra-
zil [14,30]. Our observations are consistent with the
reported variation in other H. pylori virulence factors such
as the cagA and vacA genes [31], and further emphasise the
fact that before a new virulence factor is associated with a
specific disease outcome, studies must be undertaken in a
range of geographic locations as well in different ethnic
groups.
Lu et al. have reported that, with the exception of J99,
JHP0917–JHP0918  forms a continuous open reading
frame, dupA, due to the presence of a 1 bp C/T insertion in
clinical isolates [13]. In the present study, all clinical iso-
lates sequenced possessed a continuous dupA gene, signi-
fied by the presence of the C/T insertion, a finding that is
consistent with previous reports in other populations
[13,14,32]. Our results also indicate that dupA is highly
conserved over the region sequenced with an average par-
tial sequence variation of only 1.9%. This indicates a high
degree of conservation comparable to housekeeping
genes such as atpA,  ureI,  efp, and ppa  [33]. We must
acknowledge that as only 29 clinical isolates were
sequenced and the sequences used for comparison repre-
sent less than 400 bp, the pairwise sequence variation for
the entire gene and in a larger population may be higher
than that described here. Interestingly in a recent study
Douraghi et al. compared 3 regions of the dupA gene –
JHP0917 (289 bp), JHP0918 (259 bp) and the junction
region over JHP0917 and JHP0918 i.e. 'dupA' (216 bp) in
6 Iranian strains with that of 10 Brazilian and 3 Indian
strains whose sequences had been deposited in GenBank
[32]. The reported sequence similarities in that study
ranged from 86.1%–100% for JHP0917, 88–98.8% for
JHP0918 and 93.4–99.5% for 'dupA, a finding that would
support the high degree of conservation of this gene
observed in our study. Surprisingly in the Douraghi et al.
study none of the strains were compared for all 3 regions.
The high degree of sequence conservation reported and
the finding that dupA is present in strains from different
continents and in populations with different genetic back-
grounds, suggests that dupA may confer a fitness advan-
tage of some sort, which has resulted in the conservation
of the gene and the sequence, throughout human migra-
tion. An alternate explanation, since dupA is located in the
plasticity zone, is that the acquisition was a relatively
recent phenomenon. Although there is, as yet, no specific
evidence for either scenario, we believe the former expla-
nation is more likely. Whole gene sequence analysis of
dupA over an increased sample size is necessary to ade-
quately investigate these points.
Although the initial study by Lu et al reported that dupA
was associated with IL-8 induction in vitro in both knock-
out studies and in clinical isolates [13], in the present
study we observed no significant difference in the level of
IL-8 induction between strains with or without dupA. It is
possible however that the strains used in the present study
lacked the other essential components of the dupA type IV
secretion system, however, as none of these components
have yet been identified it is impossible to assess whether
this is responsible for the lack of association with IL-8
induction in the present study. More comprehensive stud-
ies with strains lacking genes known to contribute to IL-8
induction such as cag PAI components and with oipA off
would be beneficial in elucidating the contribution of
dupA to IL-8 induction.
Conclusion
Although based on our findings and those of others, it is
unlikely that dupA is itself a determinant or indicator of a
specific clinical outcome across all populations; it may be
shown to be an important virulence factor if a role as part
of a novel TFSS is identified.
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